Recomendaciones Interinstitucionales Para Prevenir COVID-19 en Personal de Salud en Casos Sospechosos o Confirmados Por SARS-CO V2

Posted On 28 Mar 2020
Comment: Off

Por el Consejo de Emergencias Cardiovasculares y Cardiología Crítica

La situación de pandemia por el coronavirus SARS-CoV-2 es algo que no será ajeno al mundo de la cardiología. Por esto creemos importante que conozcamos los mejores métodos para protegernos de un contagio. 

La infección por SARS-CoV-2 se produce por vehiculización viral mediante gotas respiratorias producidas por la tos y /o estornudo así como por medio de contacto con superficies contaminadas producto de las mismas, la cual juega un rol primordial en la transmisión puesto que permanece con capacidad infectiva hasta 3 días dependiendo del material contaminado (3). 

En el inicio epidémico en Whuan cerca de la mitad de los casos descriptos inicialmente correspondían a personal de salud (PS). Los elementos de protección personal (EPP) se utilizan para proteger al PS, asi como a los pacientes de infectarse o prevenir que infecten a otros.

ESTRATEGIAS

  • MODIFICACIONES EDILICIAS

    Reducen la exposición del PS mediante la aplicación de barreras físicas entre la noxa y el PS. Entre ellas se encuentran, salas de aislamiento respiratorio barreras físicas: ventanas de vidrio/ plástico, sistemas de ventilación con dirección del aire del área limpia a la contaminada.

  • CONTROLES ADMINISTRATIVOS

    Son políticas y prácticas laborales que minimizan o previenen la exposición. Incluyen agrupar por casos sospechosos, confirmados, suspender visitas, etc.

  • IMPLEMENTACIÓN DEL EQUIPO DE PROTECCIÓN PERSONAL (EPP)

    Involucra un elevado nivel de entrenamiento.

EQUIPO DE PROTECCIÓN PERSONAL EN COVID-19

1. Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, et al. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. 2019;

2. Ong SWX, Yian Kim T, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA [Internet]. 2020;3–5. Available from: https://jamanetwork.com/journals/jama/fullarticle/2762692

3. Lloyd-smith JO, Munster VJ, Doremalen N Van, Bushmaker T, Morris DH, Myndi G, et al. Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 Short author list : 2020;

4. Chan JF, Yuan S, Kok K, To KK, Chu H, Yang J, et al. Articles A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission : a study of a family cluster. Lancet [Internet]. 2020;6736(20):1–10. Available from: http://dx.doi.org/10.1016/S0140-6736(20)30154-9

5. Wang D, Hu B, Peng CH, Zhu F, Zhiyong, Wang X, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;1–9.

6. Offeddu V, Yung CF, Low MSF, Tam CC. Effectiveness of masks and respirators against respiratory infections in healthcare workers: a systematic review and meta-analysis. Clin Infect Dis. 2017;65:1934–42.

7. Radonovich LJ, Simberkoff MS, Bessesen MT, Brown AC, Cummings DAT, Gaydos CA, et al. N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel A Randomized Clinical Trial. JAMA. 2019;322(9):824–33.

8. Centers for Disease Control Prevention. Coronavirus Disease 2019 (COVID-19) Strategies for Optimizing the Supply of N95 Respirators. 2020;

9. Kim JY, Song JY, Yoon YK, Choi S, Song YG, Kim S, et al. Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities. 2015;47(4):278–302.

10. World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care. 2014;1–133.

11. Interim Infection Prevention and Control Precautions for Possible or Confirmed 2019 novel Coronavirus (2019 nCoV), Middle East Respiratory Syndrome Coronavirus (MERSCoV) and Avian Influenza A in Healthcare Settings. 2020;1–26.

12. Siegel JD, Rhinehart E, Jackson M, Brennan PJ, Bell M. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. 2007;1–135.

13. Centers for Disease Control Prevention. Sequence for putting on and remove personal potective equipment (PPE).

14. European Centre for Disease Prevention and Control (ECDC). Guidance for wearing and removing personal protective equipment in healthcare settings for the the care of patients Target audience Suggested minimal PPE set. 2020;(February):1–13.

15. Europeprotective equipment in the treatment of infectious diseases of high consequence A tutorial for trainers in healthcare settings. 2014. 1–90 p.

16. World Health Organization. Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19). 2020;(February):1–7.

17. The USA Food and Drugs Administration. Surgical Mask and Gown Conservation Strategies – Letter to Healthcare Providers. 2020;1–5.

18. Centers for Disease Control Prevention.The National Institute for Occupational Safety and Health (NIOSH). The National Institute for Occupational Safety and Health Recommended Guidance for Extended Use and Limited Reuse of N95 Filtering Facepiece Respirators in Healthcare Settings. 2020;1–6. Available from: https://www.cdc.gov/niosh/topics/hcwcontrols/recommendedguidanceextuse.html

19. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect [Internet]. 2020;104(3):246–51. Available from: https://doi.org/10.1016/j.jhin.2020.01.022

20. Centers for Disease Control Prevention. Coronavirus Disease 2019 ( COVID-19 ) Environmental Cleaning and Disinfection Recommendations [Internet]. 2019. Available from: https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/cleaning-disinfection.html

21. Centre for Health Protection Hong Kong. Infection Control Branch: Use N95 respirator properly. :1–3.

22. OPS-OMS. Requerimientos para uso de equipos de protección personal ( EPP ) para el nuevo coronavirus ( 2019-nCoV ) en establecimientos de salud. 2020;1–4.an Centre for Disease Prevention and Control (ECDC). Safe use of personal.

Sobre el autor

Posts relacionados